We observed an increased frequency of caspase 3/7+ tumor-specific CD8+ T cells among WT CD8+ T cells (Fig. 2i, j) compared to Fgl2−/− CD8+ T cells (p < 0.05). This evidence concerns the gene CD8A and neoplasm.